Atrion (NASDAQ:ATRI) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Atrion (NASDAQ:ATRI) in a report released on Thursday. The brokerage issued a sell rating on the medical instruments supplier’s stock.

Atrion Stock Performance

Shares of NASDAQ:ATRI opened at $459.92 on Thursday. The firm has a market cap of $809.46 million, a price-to-earnings ratio of 43.23 and a beta of 0.69. The business has a 50-day simple moving average of $458.99 and a two-hundred day simple moving average of $445.50. Atrion has a fifty-two week low of $274.98 and a fifty-two week high of $503.24.

Atrion (NASDAQ:ATRI) last released its quarterly earnings data on Thursday, August 8th. The medical instruments supplier reported $0.23 earnings per share for the quarter. Atrion had a net margin of 10.60% and a return on equity of 7.75%. The firm had revenue of $48.77 million during the quarter.

Institutional Trading of Atrion

A number of hedge funds have recently bought and sold shares of the company. Quadrant Capital Group LLC purchased a new position in Atrion in the fourth quarter worth about $36,000. Headlands Technologies LLC purchased a new position in shares of Atrion in the second quarter worth approximately $54,000. Benjamin F. Edwards & Company Inc. bought a new stake in Atrion during the second quarter valued at approximately $72,000. EntryPoint Capital LLC purchased a new stake in Atrion during the first quarter valued at approximately $91,000. Finally, Comerica Bank raised its position in Atrion by 60.9% in the first quarter. Comerica Bank now owns 415 shares of the medical instruments supplier’s stock worth $192,000 after acquiring an additional 157 shares during the period. Hedge funds and other institutional investors own 66.19% of the company’s stock.

About Atrion

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.